481 related articles for article (PubMed ID: 24008184)
21. 5-Hydroxy-L-tryptophan alters gaboxadol pharmacokinetics in rats: involvement of PAT1 and rOat1 in gaboxadol absorption and elimination.
Larsen M; Holm R; Jensen KG; Sveigaard C; Brodin B; Nielsen CU
Eur J Pharm Sci; 2010 Jan; 39(1-3):68-75. PubMed ID: 19900542
[TBL] [Abstract][Full Text] [Related]
22. Gaboxadol has affinity for the proton-coupled amino acid transporter 1, SLC36A1 (hPAT1)--A modelling approach to determine IC(50) values of the three ionic species of gaboxadol.
Frølund S; Rapin N; Nielsen CU
Eur J Pharm Sci; 2011 Feb; 42(3):192-8. PubMed ID: 21112392
[TBL] [Abstract][Full Text] [Related]
23. The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.
Pieri M; Christian HC; Wilkins RJ; Boyd CA; Meredith D
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G136-43. PubMed ID: 20430871
[TBL] [Abstract][Full Text] [Related]
24. Intestinal gaboxadol absorption via PAT1 (SLC36A1): modified absorption in vivo following co-administration of L-tryptophan.
Larsen M; Holm R; Jensen KG; Brodin B; Nielsen CU
Br J Pharmacol; 2009 Aug; 157(8):1380-9. PubMed ID: 19594759
[TBL] [Abstract][Full Text] [Related]
25. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
[TBL] [Abstract][Full Text] [Related]
26. The transport of cationic amino acids in human airway cells: expression of system y+L activity and transepithelial delivery of NOS inhibitors.
Rotoli BM; Bussolati O; Sala R; Gazzola GC; Dall'Asta V
FASEB J; 2005 May; 19(7):810-2. PubMed ID: 15746185
[TBL] [Abstract][Full Text] [Related]
27. Intestinal absorption of the antiepileptic drug substance vigabatrin in Göttingen mini-pigs is unaffected by co-administration of amino acids.
Nøhr MK; Holm R; Thale ZI; Nielsen CU
Int J Pharm; 2014 May; 466(1-2):18-20. PubMed ID: 24607206
[TBL] [Abstract][Full Text] [Related]
28. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
29. Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na+/H+ exchange activity.
Kennedy DJ; Leibach FH; Ganapathy V; Thwaites DT
Pflugers Arch; 2002 Oct; 445(1):139-46. PubMed ID: 12397398
[TBL] [Abstract][Full Text] [Related]
30. Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.
Nielsen CU; Frølund S; Abdulhadi S; Sari H; Langthaler L; Nøhr MK; Kall MA; Brodin B; Holm R
Br J Pharmacol; 2013 Nov; 170(5):1041-52. PubMed ID: 23962042
[TBL] [Abstract][Full Text] [Related]
31. The anti-epileptic drug substance vigabatrin inhibits taurine transport in intestinal and renal cell culture models.
Plum J; Nøhr MK; Hansen SH; Holm R; Nielsen CU
Int J Pharm; 2014 Oct; 473(1-2):395-7. PubMed ID: 25062867
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor and insulin short-term increase hPepT1-mediated glycylsarcosine uptake in Caco-2 cells.
Nielsen CU; Amstrup J; Nielsen R; Steffansen B; Frokjaer S; Brodin B
Acta Physiol Scand; 2003 Jun; 178(2):139-48. PubMed ID: 12780388
[TBL] [Abstract][Full Text] [Related]
33. Studies on intestinal absorption of sulpiride (2): transepithelial transport of sulpiride across the human intestinal cell line Caco-2.
Watanabe K; Sawano T; Endo T; Sakata M; Sato J
Biol Pharm Bull; 2002 Oct; 25(10):1345-50. PubMed ID: 12392092
[TBL] [Abstract][Full Text] [Related]
34. Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells.
Neumann J; Bruch M; Gebauer S; Brandsch M
Eur J Biochem; 2004 May; 271(10):2012-7. PubMed ID: 15128310
[TBL] [Abstract][Full Text] [Related]
35. H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
Biochim Biophys Acta; 1993 Sep; 1151(2):237-45. PubMed ID: 8373798
[TBL] [Abstract][Full Text] [Related]
36. In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model.
Bravo SA; Nielsen CU; Amstrup J; Frokjaer S; Brodin B
Eur J Pharm Sci; 2004 Jan; 21(1):77-86. PubMed ID: 14706814
[TBL] [Abstract][Full Text] [Related]
37. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
Nielsen CU; Andersen R; Brodin B; Frokjaer S; Taub ME; Steffansen B
J Control Release; 2001 Sep; 76(1-2):129-38. PubMed ID: 11532319
[TBL] [Abstract][Full Text] [Related]
38. PEPT1-mediated uptake of dipeptides enhances the intestinal absorption of amino acids via transport system b(0,+).
Wenzel U; Meissner B; Döring F; Daniel H
J Cell Physiol; 2001 Feb; 186(2):251-9. PubMed ID: 11169462
[TBL] [Abstract][Full Text] [Related]
39. The orally active antihyperglycemic drug beta-guanidinopropionic acid is transported by the human proton-coupled amino acid transporter hPAT1.
Metzner L; Dorn M; Markwardt F; Brandsch M
Mol Pharm; 2009; 6(3):1006-11. PubMed ID: 19358571
[TBL] [Abstract][Full Text] [Related]
40. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
Thomsen AE; Christensen MS; Bagger MA; Steffansen B
Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
